Search results
Showing 2971 to 2985 of 7690 results
This indicator covers the proportion of eligible people with diabetes who are suspended from diabetic eye screening due to previous screening results. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG89
Agenda and papers of the NICE public board meeting on 15 May 2024
Agenda and papers of the NICE public board meeting on 13 December 2023
Read NICE's statement on modern slavery and human trafficking
Links to our annual reports and business plan
This guide describes the process NICE uses to develop NICE quality standards
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) aims to streamline patient access to safe, financially sustainable and innovative medicines.
Our policies and procedures on topics including declarations of interest, gifts and hospitality, complaints, and more.
NICE Listens is our programme of deliberative public engagement. It's used to give us an understanding of public opinion on moral, ethical and social...
Our board sets out our strategic priorities and policies. The day to day decision-making is the responsibility of our executive team . The...
NICE is committed to supporting the national agenda for achieving a sustainable health and care system.
Our recommendations on the use of highly specialised technologies are made by an independent advisory committee. This is called the highly specialised
We're bringing our guidance together by topic, so that it's all in one place, clearer to understand and easier to access. We expect that this will...
Guidance Executive
NICE's research work and partnerships with researchers, funders, charities and policy organisations.